Aggrenox MDL Nears End As Drug Cos. Reach Final Deal
By Dani Kass · June 11, 2018, 8:02 PM EDT
Teva Pharmaceutical and Boehringer Ingelheim on Monday announced a settlement with the last remaining party accusing them of entering into an illegal pay-for-delay agreement to keep a generic version of the...
To view the full article, register now.